Slc2a2 | solute carrier family 2 (facilitated glucose transporter), member 2
Physiological systems
17 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Hematopoietic system Mortality/aging
14 No significant impact
7 Not tested
Data collections
Gene metrics:3Significant phenotypes
3Associated diseases
Expression examined in:76Adult tissues
25Embryo tissues
| increased glycosylated hemoglobin level | 1 supporting dataset | Slc2a2tm1b(KOMP)Wtsi | heterozygote | Early adult | 1.12x10-5 | ||
| preweaning lethality, complete penetrance | 1 supporting dataset | Slc2a2tm1b(KOMP)Wtsi | homozygote | Early adult | N/A * | ||
| increased fasting circulating glucose level | 1 supporting dataset | Slc2a2tm1b(KOMP)Wtsi | heterozygote | Early adult | 9.09x10-5 |
| | | | | | | | | | |
External links
No external links available for Slc2a2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Slc2a2tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
| Slc2a2tm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
| Slc2a2tm1b(KOMP)Wtsi | Reporter-tagged deletion allele (with selection cassette) | | mouse |
| Slc2a2tm1e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |